Barclays lowered the firm’s price target on XPeng (XPEV) to $16 from $17 and keeps an Underweight rating on the shares post the Q4 report. The company’s Q4 revenue and gross margins were inline but its Q1 outlook is “weaker,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XPEV:
- XPeng call volume above normal and directionally bullish
- Charged: Musk to start Terafab project, Uber to invest in Rivian
- Midday Fly By: Musk to start Terafab project, Elliott takes stake in Synopsys
- Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
- Macquarie downgrades XPeng with 2026 volume growth ‘no guarantee’